New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
09:26 EDTPFE, ZTSZoetis IPO indicated to open $28.50-$29.00 on 2M shares
Zoetis (ZTS) priced 86.1M shares at $26.00. JPMorgan, BofA/Merrill and Morgan Stanley acted as joint book running managers for the offering. Note that Zoetis is the animal health unit of Pfizer (PFE), which is being spun off.
News For ZTS;PFE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 18, 2014
13:38 EDTZTSZoetis sees FY15 adjusted EPS $1.61-$1.68, consensus $1.71
Subscribe for More Information
13:32 EDTZTSZoetis trading halted, pending news
Subscribe for More Information
08:33 EDTPFEPfizer announces availability of Trumenba vaccine
Pfizer announced hat TRUMENBA, the first and only FDA-approved vaccine for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age, is now available for order by healthcare providers in the United States.
07:55 EDTZTSZoetis price target raised to $50 from $41 at Argus
Argus increased its price target on Zoetis after Bill Ackman's firm disclosed that it had acquired an 8.5% stake in the company. The firm thinks that Ackman may search for a potential buyer of Zoetis. Argus also believes that the company's margins can rise, and it keeps a Buy rating on the shares.
07:29 EDTPFEPfizer less likely to pursue AstraZeneca after PD-L1 deal, says JPMorgan
Subscribe for More Information
07:18 EDTPFEWoodford confident in Astra, sees 50% chance of new Pfizer bid, Reuters reports
Investment manager Neil Woodford of Woodford Investment Management said he now has an even stronger belief in AstraZeneca (AZN), citing the company's strong product pipeline, and put the chances of a new takeover bid from Pfizer (PFE) at 50/50, reported Reuters, citing a statement from Woodford. Reference Link
07:00 EDTZTSZoetis announces authorization of $500M share repurchase program
Subscribe for More Information
06:49 EDTZTSValeant likely to pursue more moderate-sized deals, says Piper Jaffray
Subscribe for More Information
06:39 EDTPFEAstraZeneca: 'Hard to comment' on whether Pfizer will come back, Reuters reports
Subscribe for More Information
November 17, 2014
14:27 EDTPFEPfizer volatility flat into investor meeting
Subscribe for More Information
10:40 EDTZTSZoetis to host investor day
Subscribe for More Information
09:42 EDTPFEPfizer to host investor day
Subscribe for More Information
09:22 EDTPFEOn The Fly: Pre-market Movers
Subscribe for More Information
08:16 EDTZTSZoetis to purchase assets of Abbott Animal Health for about $255M
Subscribe for More Information
08:15 EDTZTSZoetis to purchase assets of Abbott Animal Health for about $255M
08:13 EDTPFEPortola, Bristol-Myers, Pfizer announce results from Phase 3 ANNEXA-A studies
Subscribe for More Information
07:16 EDTPFEMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
06:43 EDTPFEAstraZeneca, Pfizer deal seen less likely after Merck transaction, Reuters says
Subscribe for More Information
05:27 EDTPFEPfizer lowers FY14 Reported EPS view to $1.40-$1.49 from $1.50-$1.59
Subscribe for More Information
05:23 EDTPFEPfizer forms strategic alliance with Merck KGaA
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use